Abstract
Glioblastoma multiforme (GBM: grade IV astrocytoma) is the most common but lethal form of brain cancer. The median survival time of GBM patients is only 15 months. Only a few predictive markers have been reported for prognosis and treatment.
This study integrates gene expression and protein-protein interaction data to search for pathways that are differentially regulated between long-term and short-term survivors of GBM patients. A novel objective function for greedy search was introduced in search for 47 significantly and differentially expressed sub-networks (SDES) or pathways in a greedy fashion. The resultant putative pathways (involving 156 genes) were tested for enrichment of known GBM cancer genes as well as GO terms related to “biological process.” Integration of gene expression profiles of GBM patients with a PPI network improves the recall rate of known GBM driver genes and shows the better GO enrichment in comparison to the conventional gene-set approach that is based solely on the expression data.
Keywords: Brain, cancer, GBM, gene, integration, pathway, PPI, protein, sub-network.
Current Bioinformatics
Title:Mining of Network Markers for Brain Tumor from Transcriptome and Interactome Data
Volume: 8 Issue: 3
Author(s): Jongkwang Kim
Affiliation:
Keywords: Brain, cancer, GBM, gene, integration, pathway, PPI, protein, sub-network.
Abstract: Glioblastoma multiforme (GBM: grade IV astrocytoma) is the most common but lethal form of brain cancer. The median survival time of GBM patients is only 15 months. Only a few predictive markers have been reported for prognosis and treatment.
This study integrates gene expression and protein-protein interaction data to search for pathways that are differentially regulated between long-term and short-term survivors of GBM patients. A novel objective function for greedy search was introduced in search for 47 significantly and differentially expressed sub-networks (SDES) or pathways in a greedy fashion. The resultant putative pathways (involving 156 genes) were tested for enrichment of known GBM cancer genes as well as GO terms related to “biological process.” Integration of gene expression profiles of GBM patients with a PPI network improves the recall rate of known GBM driver genes and shows the better GO enrichment in comparison to the conventional gene-set approach that is based solely on the expression data.
Export Options
About this article
Cite this article as:
Kim Jongkwang, Mining of Network Markers for Brain Tumor from Transcriptome and Interactome Data, Current Bioinformatics 2013; 8 (3) . https://dx.doi.org/10.2174/1574893611308030005
DOI https://dx.doi.org/10.2174/1574893611308030005 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design of Magnetic Nanoparticles-Assisted Drug Delivery System
Current Pharmaceutical Design Exploring Genetic Influences on Cognition: Emerging Strategies for Target Validation and Treatment Optimization
Current Drug Targets - CNS & Neurological Disorders Glycomics: Relevance for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Multiple Target-Specific Molecular Agents for Detection and Image Analysis of Breast Cancer Characteristics in Mice
Current Molecular Medicine Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor Biology
Current Pharmaceutical Design Can Genetics Help in Treatment of Smoking Addiction?
Current Pharmacogenomics and Personalized Medicine The Concept of Depression as a Dysfunction of the Immune System
Current Immunology Reviews (Discontinued) Regulatory Approaches to Nonclinical Reproductive Toxicity Testing of Anti-Cancer Drugs
Anti-Cancer Agents in Medicinal Chemistry Multifuntional Nanoparticles: Preparation and Applications in Biomedicine and in Non-Invasive Bioimaging
Recent Patents on Nanotechnology Defensins: Key Molecules in Ocular Surface Protection
Current Immunology Reviews (Discontinued) The Stress Response: Implications for the Clinical Development of Hsp90 Inhibitors
Current Cancer Drug Targets Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Methotrexate: A Drug of the Future in Ulcerative Colitis?
Current Drug Targets Potential Gene Therapy Strategies for Cancer Stem Cells
Current Gene Therapy The Plant Resources, Structure Characteristics, Biological Activities and Synthesis of Pyranoflavonoids
Current Medicinal Chemistry Palladium-Catalyzed Oxyarylation, Azaarylation and α-Arylation Reactions in the Synthesis of Bioactive Isoflavonoid Analogues
Current Organic Synthesis Advances in the Discovery of Anthraquinone-Based Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Targeting the Viral Nucleocapsid Protein in Anti-HIV-1 Therapy
Mini-Reviews in Medicinal Chemistry β-Lactone Derivatives and Their Anticancer Activities: A Short Review
Current Topics in Medicinal Chemistry Sentinel Node Imaging
Current Medical Imaging